...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

,,I agree,,,,,,,I spoke to an investor who has known this company from day one and DMcC, they said they stopped being a shareholder a number of years ago because of our CEOs blatant insincerity around what he passed on to shareholders. Anything goes! Its theatrics to excite the shareholder base and those on the sidelines. They noted its the tactics of an event promoter, something out of Don Kings handbook and its easy to see the resemblance when a presentation is made.

That doesnt mean the science is fraudulant or other. It only means we cant base present or future investment on what our CEO tells us. Unfortunate but its reality.

They also noted the brown manila envelope has been used over the years to the fan base where he tells the audience if they only knew what was in this envelope and of course wished he could pass on that info to shareholders. It sounds legit! And is still in almost every presentation he gives.

And as we have read from other posters when you disagree or question RVX then you get escorted ouit of the meeting!!!,,Pitiful,,a sign of weak oragnizational skills and respect for shareholders. JMO

Share
New Message
Please login to post a reply